Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.
about
Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicityInnate immunity and cardiomyocytes in ischemic heart diseaseInnate immunity in human embryonic stem cells: comparison with adult human endothelial cellsSchisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signalingHeat shock protein 25-enriched plasma transfusion preconditions the heart against doxorubicin-induced dilated cardiomyopathy in mice.Ginkgolide B Exerts Cardioprotective Properties against Doxorubicin-Induced Cardiotoxicity by Regulating Reactive Oxygen Species, Akt and Calcium Signaling Pathways In Vitro and In VivoCardiomyocyte death in doxorubicin-induced cardiotoxicityAndrogen receptor counteracts Doxorubicin-induced cardiotoxicity in male miceVitamin E and telmisartan attenuates doxorubicin induced cardiac injury in rat through down regulation of inflammatory response.Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice.Focal adhesion kinase antagonizes doxorubicin cardiotoxicity via p21(Cip1.).Long pentraxin PTX3 exacerbates pressure overload-induced left ventricular dysfunctionDifferential regulation of diacylglycerol kinase isoform in human failing heartsSenescence marker protein 30 has a cardio-protective role in doxorubicin-induced cardiac dysfunction.Independent roles of the priming and the triggering of the NLRP3 inflammasome in the heart.The role of renin angiotensin system antagonists in the prevention of doxorubicin and trastuzumab induced cardiotoxicityApoptosis in Anthracycline CardiomyopathyAssociation of Toll-like receptor 4 polymorphism with age-dependent systolic blood pressure increase in patients with coronary artery disease.Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin.Heat shock factor-1 knockout induces multidrug resistance gene, MDR1b, and enhances P-glycoprotein (ABCB1)-based drug extrusion in the heart.Diacylglycerol kinase zeta inhibits myocardial atrophy and restores cardiac dysfunction in streptozotocin-induced diabetes mellitus.Toll-like receptor modulation in cardiovascular disease: a target for intervention?HECT-Type Ubiquitin E3 Ligase ITCH Interacts With Thioredoxin-Interacting Protein and Ameliorates Reactive Oxygen Species-Induced Cardiotoxicity.NLRP3 Deficiency Reduces Macrophage Interleukin-10 Production and Enhances the Susceptibility to Doxorubicin-induced Cardiotoxicity.Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitroDoxorubicin induces the persistent activation of intracellular transglutaminase 2 that protects from cell deathDHA derivatives of fish oil as dietary supplements: a nutrition-based drug discovery approach for therapies to prevent metabolic cardiotoxicity.Toll-like receptors as potential therapeutic targets in cardiac dysfunction.Mechanisms and management of doxorubicin cardiotoxicity.Anthracycline-Induced Cardiomyopathy in Adults.Hsp70 regulates the doxorubicin-mediated heart failure in Hsp70-transgenic mice.Inflammation and metabolic cardiomyopathy.Combination stem cell therapy for heart failure.Innate immunity and remodelling.Sarco"MiR" friend or foe: a perspective on the mechanisms of doxorubicin-induced cardiomyopathy.Neferine ameliorates cardiomyoblast apoptosis induced by doxorubicin: possible role in modulating NADPH oxidase/ROS-mediated NFκB redox signaling cascade.TNF/TNF-R1 pathway is involved in doxorubicin-induced acute sterile inflammation.Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis.Cardioprotective effects of nicorandil, a mitochondrial potassium channel opener against doxorubicin-induced cardiotoxicity in rats.Deficiency of senescence marker protein 30 exacerbates angiotensin II-induced cardiac remodelling.
P2860
Q24648835-A0B7CE72-F962-43A4-9475-B39C0906A203Q27003911-C1410208-E91B-468D-8915-EC0BDECAEECAQ27329616-D9DEAFD3-73B2-43CA-A0DC-CC825EE9FD1CQ28543891-CD1CAFF7-CB4E-44DD-B184-4991FA5E6016Q30514253-18523433-4E05-4B7A-86A9-28F0C3E33B02Q32183971-8D47C424-3300-4101-9E7F-B18134D936DCQ33604134-36C1AA57-AD39-4F97-AF32-4471F3A659ACQ33637455-C7F725C3-8903-4153-B0AE-9171C3DF7D48Q34292480-359EEFDD-F572-4DE6-9087-10775A854619Q34342389-376BDA5F-748D-4021-ABDD-6D60E3E98AD3Q34541922-C8DBF2BE-1D83-4F65-95BE-796FEC0B5197Q34570880-081A5A2F-5355-4FD2-9203-39CA5B9A027AQ35027183-D574CA83-73C2-4E7C-B984-36222711D1F4Q35082301-09AF3C58-7964-4B1E-A937-5E4BC15365E1Q35171781-E82952A6-D4EF-4800-BC0B-03B3D27D1F3BQ35368603-5C841844-7FB1-4426-8BF1-B53336FE7635Q35642302-A274E390-0941-450E-A135-26C444EDE391Q35646051-D86E898C-0A52-416F-8FA8-F7E4EC8EB698Q36022217-8E314CEC-4178-4F41-A3CF-C7ECC6ED1113Q36061338-EB9DD48E-5484-42A6-BA46-6182E64639CAQ36492259-95FFFBFB-0EA8-4442-BD53-1DB6356D5059Q36543054-DCAE5B38-F339-46DE-A9B9-1D0B9FE1EEDCQ36877602-953FCCC2-476D-46AC-91EC-6341D4CE413AQ36937463-BA8A7BE3-05CC-4377-8584-FBCFE36D53B6Q37200311-D2784C99-F456-4CC3-B505-9BCCE8062750Q37461477-71570DB7-E09E-4E94-B6FC-4A265BC3FB52Q37671776-65CA72D9-FF8F-4C3F-AE7C-5ABCD3EC3772Q37850809-EF20CC57-022B-43C1-983C-3BAC1F4EB478Q38473474-3FFD5D7E-E8AF-4FCA-A13A-308A8CC65EDBQ38542462-074A8DFC-3ABB-4937-9A8A-F0E4200A7D8AQ39002626-15A1E0D4-86A4-4D08-B518-EEEFC44B9ECEQ39232024-E7BCCE3F-9919-47B1-8F84-9BF76FAED405Q41194503-B463C3B5-25D0-4A12-B0AB-5E002E499D7DQ41208076-AF271FE1-08AF-4FCE-A1B1-7266547F5897Q41983421-4D73333C-F5E9-44F2-A602-4D12D2834610Q42363693-A1C93962-0FE8-437D-B7B5-EECBBC2B71E2Q42766535-02924504-5A83-4225-A1AB-6317C1FED2BEQ42964167-1AC522EB-1F8B-4DA5-AA1D-4FC293F0D3CBQ43972291-653F0484-468F-4A51-8AFB-8EC318323156Q44425186-3090C369-C7F8-4B03-8B0D-74087C9913CF
P2860
Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@en
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@nl
type
label
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@en
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@nl
prefLabel
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@en
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@nl
P2093
P1433
P1476
Modulation of doxorubicin-indu ...... like receptor-2-knockout mice.
@en
P2093
Isao Kubota
Naoki Nozaki
Tetsuro Shishido
Yasuchika Takeishi
P304
P356
10.1161/01.CIR.0000146889.46519.27
P407
P577
2004-10-25T00:00:00Z